SCHEMBL9539429

SCHEMBL9539429

C#CC1(COCOCCOC)NC(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PDE7A Q13946 3/20 0.39
AKR1B1 P15121 5/20 0.37
IDO1 P14902 2/20 0.33
AKR1A1 P14550 1/20 0.32
CBX7 O95931 1/20 0.31
CDYL Q9Y232 1/20 0.31
ALPL P05186 1/20 0.31
MMP2 P08253 1/20 0.30
MMP3 P08254 1/20 0.30
MMP8 P22894 1/20 0.30
MMP14 P50281 1/20 0.30
MMP17 Q9ULZ9 1/20 0.30
CYP46A1 Q9Y6A2 1/20 0.30
ADAMTS5 Q9UNA0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9540091 0.91 PDE7A (0.41) PDE7AAKR1B1IDO1AKR1A1CBX7
SCHEMBL9542716 0.84 PDE7A (0.43) PDE7AAKR1B1IDO1AKR1A1CBX7
SCHEMBL9539036 0.83 PDE7A (0.34) PDE7AAKR1B1ALPL
SCHEMBL27447100 0.79
SCHEMBL9540124 0.79 PDE7A (0.42) PDE7AAKR1B1IDO1AKR1A1CBX7
SCHEMBL9539434 0.76 PDE7A (0.38) PDE7AAKR1B1IDO1AKR1A1CBX7
SCHEMBL9542856 0.76 PDE7A (0.46) PDE7AAKR1B1IDO1AKR1A1CBX7
SCHEMBL9539058 0.75 PDE7A (0.48) PDE7AAKR1B1IDO1AKR1A1CBX7
SCHEMBL9541372 0.72 AKR1B1 (0.45) PDE7AAKR1B1IDO1AKR1A1CYP46A1
SCHEMBL9539786 0.72 PDE7A (0.39) PDE7AAKR1B1IDO1AKR1A1CBX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0530994-A1 Quinazoline derivatives as inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1993-03-10 EP disclosed
WO-1993004047-A1 QUINAZOLINE DERIVATIVES AS INHIBITORS OF HIV REVERSE TRANSCRIPTASE MERCK & CO., INC. (US) 1993-03-04 WO disclosed